US Patent Issued to Flow Pharma on Sept. 8 for "Controlled release of antibodies to modulate cytokines" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,237, issued on Sept. 8, was assigned to Flow Pharma Inc. (Redwood City, Calif.).

"Controlled release of antibodies to modulate cytokines" was invented by Reid M. Rubsamen (Alamno, Calif.), Scott Burkholtz (Redwood City, Calif.), Charles V. Herst (Oakland, Calif.), Tom Hodge (Redwood City, Calif.) and Lu Wang (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An injectable formulation, comprising: poly(lactic-co-glycolic (PLGA) microsphere encapsulating siltuximab, wherein microspheres are sized to release siltuximab over a period of hours, days and weeks, where the biocompatible polymer releases antibody at an absorption rate which is ...